Regeneron Pharmaceuticals, Inc… (NASDAQ:REGN)

sadness check box

Regeneron Downgrade Highlights at Least Some Risks

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) seems to have held up rather well against an analyst downgrade on Wednesday. Canaccord Genuity lowered its official rating to Hold from Buy. While the ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Stocks were indicated lower after companies like Apple, Boeing and AT&T were taking shareholders down after earnings. The volatility in 2016 remains in place. While investors may have seen every ...
Read Full Story »
Biotechnology word cloud

UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings

If there has been one sector that wishes the 2016 election was already here and gone, it is biotechnology. Shrill political rhetoric over drug pricing and further regulations hammered the ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More

Stocks were indicated higher on Friday going into the unemployment and payrolls report. Investors want to keep buying value and discounted shares on the dips. That trend is now four ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amgen, Dow, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum and Many More

Stocks were indicated substantially higher on Tuesday morning after the Labor Day weekend. China shares were higher, as was Europe. The trend of buying pullbacks lives on. 24/7 Wall St. ...
Read Full Story »
Sell Button

4 Stocks to Sell Now, Until the Fed Acts

Monday was historic. The Dow Jones had a 7% intraday trading range. The Nasdaq was even more volatile with a 9% intraday trading range. The S&P 500 had gained more ...
Read Full Story »
biotech

3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming

With many now expecting interest rates to finally start the move higher as early as next month, it is a fascinating study to see how interest rates affect biotech stocks. ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Cheniere, First Solar, Hilton, NOV, Disney and Many More

Stocks traded higher early Wednesday, a show that yet again investors are buyers after every stock market dip. That trend is now almost four years old, although the reason for buying the ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Baidu, BlackBerry, GM, PayPal, Teva, Yelp and Many More

Stocks were indicated higher on Tuesday morning after 5 days in a row of selling. Yet again we see the trend of investors finding a reason to buy every stock ...
Read Full Story »
Biotechnology word cloud

Have Analysts Fully Priced in Praluent to Regeneron?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Exxon, LifeLock, Microsoft, PayPal, Chipotle and More

Stocks were lower on Wednesday morning as investors are selling more earnings reports. Still, the one trend that has held up for almost four years now is that investors have ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Alarm.com, Pandora, PayPal, SanDisk, SunEdison, Tesla, AMD and More

Stocks were looking for direction on Tuesday as the earnings onslaught begins. One trend that has held up for almost four years now is that investors have bought every stock ...
Read Full Story »
amgnlogo

4 Large Cap Biotech Stocks to Buy Before Earnings

The biotech industry has been on an outstanding run over the past year, and some top analysts on Wall Street think that run could be poised to continue. A new ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, Envestnet, Pandora, Regeneron, Spectra, Travelers and More

Stocks were indicated up sharply on Thursday morning as China banned large stakeholders and insiders from selling shares in an effort to stop the sell-off. Yet again, the trend that ...
Read Full Story »
fda_logo

5 Big Upcoming FDA Decisions Expected in July

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »